1 study found for:    NCT00844844
Show Display Options
Rank Status Study
1 Completed Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: Eculizumab

Indicates status has not been verified in more than two years